May 20, 2022
Tact.ai at the Next Pharma Summit 2022
This week on May 17th and 18th, our team at Tact.ai attended the Next Pharma Summit 2022.Our team was delighted to be a part of the discussions about the future of customer engage
Tact.ai is on a mission to help life science organizations nurture meaningful customer engagement through our human-friendly software.
“The COVID-19 pandemic drove new imperatives to realize the power of data and technologies such as digital and virtual engagement that had been sitting at the peripheries for years.
Support for hybrid engagement strategy is a must in the post pandemic normal”
Tact Content Player for Microsoft Teams allows customer-facing teams to connect where customers prefer by supporting compliant video meetings on Microsoft Teams, sharing compliant content to enable better customer access and an improved user experience.
Customer Friendly Email (CFE) offers a reimagined compliant email experience created to help teams send more personalized communications, and appear in their customers’ inboxes more frequently with results as high as 1.5x industry open-rates.
Tact.ai welcomes two new pharma executives as board advisors to accelerate innovation in life sciences customer engagement. Giuseppe Firenze, Global Commercial Information Officer of Eli Lilly and Company, and Desmond Creary, Chief Customer Engagement Officer for Novartis US. Giuseppe and Desmond will play key roles in the development of the platform’s advanced capabilities to help deliver innovative medicines to more patients faster.
This week on May 17th and 18th, our team at Tact.ai attended the Next Pharma Summit 2022.Our team was delighted to be a part of the discussions about the future of customer engage
On Saturday, April 2nd, we at Tact.ai attended the 71st Annual American College of Cardiology Scientific Sessions (ACC.22) in Washington, D.C.
A must read definitive guide to understanding evolution of HCP engagement post COVID-19
"As healthcare organizations prioritize interactions that improve patient outcomes, the opportunity to bring to market a next generation engagement platform for biopharma has emerged, Tact.ai supports our thesis that commercial strategies for biopharma should account for both field force and prescriber needs, ensuring the right data is leveraged at the right time to enable the best decisions and support for patients."
"Our Commercial and Medical teams at Novartis have been collaborating with Tact over the last two years to transform our field force and customer experience globally. Tact.ai aligns with our ambition to reimagine customer engagement for the New Normal."
Sales Performance Management
AI 100 Ranking - Sales and CRM
Life Science Commercial Operations
CRM Sales Technology
Top Sales Productivity Solutions
